Author Archives for Adeline Chauvigné

CE4BIG: A EUROPEAN PROJECT COORDINATED BY THE SELECTED AND FUNDED CLUSTER

10 May 2025

In 2019, the European project CE4BIG – Cluster Excellence for Business Innovation and Growth in the Health Sector – was... View Article

RELIEF, A STRATEGIC PROJECT FOR GLIOCURE, SELECTED BY EUREKA !

10 May 2025

Angers, 20th January 2020 – GlioCure SAS, a biotechnology company specialising in the field of neuro-oncology and a member of... View Article

FIGHTING CANCER WITH LASERS: A PROJECT DRIVEN BY PROFESSIONALS IN THE LANNION AREA APPROVED BY IMAGES ET RÉSEAUX AND ATLANPOLE BIOTHERAPIES

10 May 2025

Seven researchers in Lannion are working on the UV4life project, approved by Images et Réseaux and Atlanpole Biotherapies and supported... View Article

Goliver Therapeutics, partnering the Paul Brousse Hospital in Villejuif

10 May 2025

REGENERATIVE MEDECINE – AN ALTERNATIVE TO LIVER TRANSPLANTS In Nantes, on 9th December 2019, GoLiver Therapeutics, a start-up and member... View Article

DIRECTOSANTÉ aims to enhance the follow-up care of ambulatory patients in hospital environments

10 May 2025

DIRECTOSANTÉ, AN E-HEALTH START-UP AND MEMBER OF THE ATLANPOLE BIOTHERAPIES COMPETITIVE CLUSTER, HAS SUCCESSFULLY COMPLETED ITS SECOND FUND-RAISING INITIATIVE AMOUNTING... View Article

The Angers University Hospital (CHU), a driving force in research and innovation

10 May 2025

LATE 2019 AND EARLY 2020 WERE MARKED BY STRONG INNOVATION AT THE ANGERS CHU. THE HOSPITAL ESTABLISHED SEVERAL PARTNERSHIPS AIMED... View Article

Atlanpole Biotherapies excellence and expertise recognized at European level

10 May 2025

Already structured to conduct international efforts, the cluster is now expanding its missions focus towards its members. Atlanpole Biotherapies is... View Article

Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed

10 May 2025

The Company also confirms its mid-term intention to list on Nasdaq to co-fund late stage development of its Lyme disease... View Article

New member | Vigier Avocats

10 May 2025

Making the practice of law an asset! Vigier Avocats is an independent business law with a solid expertise in the... View Article

New member | Olgram

10 May 2025

Olgram transforms a natural marine molecule into a drug to stimulate the immune system and develops new classes of antibiotics.... View Article